Received May 6, 2026
Reports are unverified and do not show that a vaccine caused an event. Full disclaimer
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PPV | PNEUMO (PNEUMOVAX) | MERCK & CO. INC. | UNK | Y012511 | OT |
The patient is not experiencing any adverse events.; patient received an expired PNEUMOVAX® 23 (pneumococcal vaccine polyvalent); This spontaneous report was received from a medical assistant and refers to a 73-year-old female patient. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 13-Apr-2026, the patient was vaccinated with Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX 23) (lot #Y012511 with valid expiration date reported as 20-Mar-2026) 0.5 mL (frequency: single) administered by intramuscular route (vaccination site was not reported) for prophylaxis. On that day, she received as expired Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX 23) (expired product administered). The patient was not experiencing any adverse events (no adverse event). The Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX 23) in question was never involved in a temperature excursion and was supported by a post expiry memo. No product quality complaint (PQC) was noted.